Int J Pharm Investig. 2013 Oct;3(4):217-24. doi: 10.4103/2230-973X.121306.

Development and evaluation of 6-mercaptopurine and metoclopramide polypill formulation for oral administration: In-vitro and ex vivo studies.

International journal of pharmaceutical investigation

Rajani Chowdhary, Roopa S Pai, Gurinder Singh

PMID: 24350042 PMCID: PMC3853762 DOI: 10.4103/2230-973X.121306

Abstract

INTRODUCTION: The present investigation was to develop a polypill of 6-mercaptopurine and metoclopramide. A polypill with delayed release granules of an anticancer and immediate release mucoadhesive tablet of antiemetic may result in the reduction of emesis caused by oral chemotherapy.

MATERIALS AND METHODS: 6-Mercaptopurine granules were prepared by wet granulation process. Chitosan, hydroxypropyl methylcellulose, and ethylcellulose were used as individually as delayed release polymers. Seven granule formulations (F1-F7) were prepared and evaluated for flow properties and drug content. Immediate release mucoadhesive tablets of metoclopramide were prepared by direct compression technique using pectin and PVPK-40 as mucoadhesive polymers. Three formulations of pectin (L1-L3) and three formulations of PVPK40 (M1-M3) were prepared using lactose, magnesium stearate, and mannitol and talc as diluent and glidant, respectively. Tablets were evaluated for weight variation, hardness, friability, drug content, ex vivo mucoadhesion time, and in vitro dissolution studies.

RESULTS: Formulation F2, F4, F5, and F7 showed maximum drug content. Formulation F7 exhibited the drug release up to 2 h and was selected as the best delayed release formulation. All formulations of metoclopramide showed good drug content ranging from 97.6 % to 100.6%. Formulation M2 among tablets prepared with PVP exhibited desired mucoadhesion time of 15.33 min which prolongs the duration of drug release in gastric pouch of the male Wistar rats. Both the selected formulations F7 and M2 were filled into body of capsule size 0 and capsule was evaluated for technological properties.

CONCLUSION: It may be concluded that polypill released the metoclopramide immediately prior to 6-mercaptopurine.

Keywords: 6-mercaptopurine; delayed release; immediate release; metoclopramide; polypill

References

1. Oncologist. 2003;8(2):187-98 - PubMed
2. Eur J Pharm Sci. 2007 Dec;32(4-5):296-307 - PubMed
3. Oncology (Williston Park). 1998 Mar;12(3 Suppl 4):38-42 - PubMed
4. Int J Pharm. 2004 Nov 22;286(1-2):27-39 - PubMed
5. J Pharm Sci. 1992 Jan;81(1):1-10 - PubMed
6. J Adv Pharm Technol Res. 2012 Jan;3(1):30-40 - PubMed
7. J Adv Pharm Technol Res. 2012 Apr;3(2):130-5 - PubMed
8. Intern Med J. 2005 Aug;35(8):478-81 - PubMed
9. Manag Care Interface. 2002 Jul;15(7):55-62 - PubMed
10. J Young Pharm. 2012 Jul;4(3):146-56 - PubMed

Publication Types

• Journal Article